Antengene Corporation Announces Exclusive Worldwide License to...
SHANGHAI and LONDON, Nov. 7, 2019 /PRNewswire-AsiaNet/ -- Antengene Corporation today announced that it has entered into a licensing agreement with AstraZeneca (LSE/STO/NYSE: AZN) under which Antengene has been granted the exclusive global rights to further develop and commercialize AZD0364. Antengene Co...
Authors: LATEST ASIANET NEWS RELEASES